ETFsXtrackers MSCI World ex USA UCITS ETF 1D
Xtrackers
Xtrackers MSCI World ex USA UCITS ETF 1D
EXU1 LSEDistributingIreland
Last close · EUR
11.26EUR
-1.48% · -€0.17
Published closes: 4 Nov 2026 - 5 Nov 2026
5 Nov 2026, close
EXU1Base
- Fund charges
- Not publishedFee basis unverified
- Fund size
- Not published
- Return 1Y
- +18.3%
- Sharpe 3Y
- Not published
- Volatility 1Y
- 11.5%annualised
- Holdings
- 734Fund holdings
Performance
Compare
- EXU1+18.3%
- Price, EUR
Returns
| Returns | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|
| EXU1 | +0.5% | 0.0% | +8.2% | +15.5% | +18.3% | - | - |
| MSCI World | -2.8% | -0.6% | +7.8% | +14.3% | +14.1% | +65.6% | +64.8% |
| Gap to MSCI World | +3.3% | +0.6% | +0.4% | +1.2% | +4.2% | - | - |
Risk and return
Sharpe ratio · 1Y
1.34
Above MSCI World · 1.28- Return p.a.
- +18.5%
- Volatility
- 11.5%
- Max loss
- -8.6%Mar 2026
Sharpe vs indices
EXU1
1.34
MSCI World
1.28
S&P 500
1.16
STOXX Europe 600
0.99
MSCI Emerging Markets IMI
0.76
CAC 40
-0.01
Method
Weekly EUR returns from adjusted closes. Sharpe is the annualised excess return over the euro overnight rate (Xtrackers II EUR Overnight Rate Swap UCITS ETF 1C) divided by its volatility. Max loss uses daily closes.
Top holdings
- Top 10
- 12.7%
- Holdings
- 734
- As of
- 1ASML HOLDINGNL00102732152.37%
- 2ROCHE PS PAR AGCH14990599831.38%
- 3HSBC HOLDINGS PLCGB00054052861.24%
- 4NOVARTIS AGCH00120052671.22%
- 5SHELLGB00BP6MXD841.20%
- 6ROYAL BANK OF CANADACA78008710211.18%
- 7ASTRAZENECA PLCGB00098952921.16%
- 8NESTLE SACH00388633501.10%
- 9SAPDE00071646000.99%
- 10MITSUBISHI UFJ FINANCIAL GROUPJP39029000040.92%
Countries
Classified 100.0%
Japan20.2%
Canada12.3%
GB
Other9.5%
CH
FR
DE
AU
NL
ES
IT
SE
- Largest
- 20.2%Japan
- Top 3
- 43.5%
- Effective number
- 10.11 / HHI
Market cap
Weight vs holdings
12.7%of the fund sits in the top 10 holdings
12.7%23.3%34.8%28.9%
WeightHoldings
150534
- Holdings 1-10
- Holdings 11-50
- Holdings 51-200
- Holdings 201+
Size split
Not published
Compare ETFs in Copio.
Factual research, without a suitability score or investment recommendation. Past relationships can change.
